| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adverse Events in Twitter-Development of a Benchmark Reference Dataset: Results from IMI WEB-RADR
|
Dietrich, Juergen
|
|
|
43 |
5 |
p. 467-478
|
artikel
|
| 2 |
An Evaluation of Postmarketing Reports with an Outcome of Death in the US FDA Adverse Event Reporting System
|
Marwitz, Kathryn
|
|
|
43 |
5 |
p. 457-465
|
artikel
|
| 3 |
Chloroquine for COVID-19 Infection
|
Moore, Nicholas
|
|
|
43 |
5 |
p. 393-394
|
artikel
|
| 4 |
Comment on ‘Reported Severe Hypersensitivity Reactions after Intravenous Iron Administration in the European Economic Area (EEA) Before and After Implementation of Risk Minimization Measures’
|
Schaffalitzky de Muckadell, Philip
|
|
|
43 |
5 |
p. 503-505
|
artikel
|
| 5 |
Developing Predictive Models to Determine Patients in End-of-Life Care in Administrative Datasets
|
Swerdel, Joel N.
|
|
|
43 |
5 |
p. 447-455
|
artikel
|
| 6 |
Disproportionality Analysis for Pharmacovigilance Signal Detection in Small Databases or Subsets: Recommendations for Limiting False-Positive Associations
|
Caster, Ola
|
|
|
43 |
5 |
p. 479-487
|
artikel
|
| 7 |
Hyperkeratotic Skin Adverse Events Induced by Anticancer Treatments: A Comprehensive Review
|
Vastarella, Maria
|
|
|
43 |
5 |
p. 395-408
|
artikel
|
| 8 |
Quality of Reporting on the Evaluation of Risk Minimization Programs: A Systematic Review
|
Russell, Andrea M.
|
|
|
43 |
5 |
p. 427-446
|
artikel
|
| 9 |
Safety of Eosinophil-Depleting Therapy for Severe, Eosinophilic Asthma: Focus on Benralizumab
|
Jackson, David J.
|
|
|
43 |
5 |
p. 409-425
|
artikel
|
| 10 |
Sex Differences in Adverse Drug Reactions of Metformin: A Longitudinal Survey Study
|
de Vries, Sieta T.
|
|
|
43 |
5 |
p. 489-495
|
artikel
|
| 11 |
Systemic Adverse Events Associated with Compounded Topical Pain Products
|
Kim, Jenny
|
|
|
43 |
5 |
p. 497-501
|
artikel
|
Tijdschrift beschrijving